Exorcising ghosts and unwelcome guests

Annals of Internal Medicine

Volumn 143, Issue 8, 2005, Pages 611-612

  Laine, Christine ^a   Mulrow, Cynthia D ^b  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COOPERATION; ETHICS; FINANCIAL MANAGEMENT; HUMAN; MARKETING; MEDICAL LITERATURE; MEDICAL RESEARCH; ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTECTION; PUBLICATION; REVIEW; STANDARD; WRITING; BIOMEDICAL AND BEHAVIORAL RESEARCH; NOTE; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

AUTHORSHIP; HUMANS; PERIODICALS; UNITED STATES; WRITING;

EID: 26944468253     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-8-200510180-00013     Document Type: Review

References (12)

1. Lisse JR, Perlman M, Johansson G, Shoemaker JR, Schechtman J, Skalky CS, et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Intern Med. 2003;139:539-46. [PMID: 14530224]
2. Berenson A. Evidence in Vioxx suits shows intervention by Merck officials. New York Times. 2005;24 April.
3. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Accessed at www.ICMJE.org.
4. Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin. 2003;19:149-54. [PMID: 12814125]
5. Mello MM, Clarridge BR, Studdert DM. Academic medical centers' standards for clinical-trial agreements with industry. N Engl J Med. 2005;352:2202-10. [PMID: 15917385]
6. Martinson BC, Anderson MS, de Vries R. Scientists behaving badly. Nature. 2005;435:737-8. [PMID: 15944677]
7. Flanagin A, Carey LA, Fontanarosa PB, Phillips SG, Pace BP, Lundberg GD, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280:222-4. [PMID: 9676661]
8. Fugh-Berman A. The corporate coauthor. J Gen Intern Med. 2005;20:546-8. [PMID: 15987332]
9. Food and Drug Administration. Final guidance on industry-supported scientific and educational activities. Notice. Accessed at www.fda.gov/cber/ gdlns /sciedu.pdf.
10. Daskalopoulou SS, Mikhailidis DP. The involvement of professional medical writers in medical publications [Editorial]. Curr Med Res Opin. 2005;21:307-10. [PMID: 15802002]
11. Jacobs A, Carpenter J, Donnelly J, Klapproth JF, Gertel A, Hall G, et al. The involvement of professional medical writers in medical publications: results of a Delphi study. Curr Med Res Opin. 2005;21:311-6. [PMID: 15818870]
12. World Association of Medical Editors. Ghost Writing Initiated by Commercial Companies. Posted 19 April 2005; revised 20 June 2005. Accessed at www .wame.org/wamestmt.htm#ghostWAME on 13 July 2005.